《国际循环》:您的数据提示女性患者对瑞舒伐他汀的疗效反应较阿托伐他汀更好,如何解释这一结果?
International Circulation: Your data shows that the female subgroup had a better response to rosuvastatin than to atorvastatin. Do you have an explanation for that?
目的观察瑞舒伐他汀和阿托伐他汀对氯吡格雷抗血小板活性的影响。
Objective to observe the influence of rosuvastatin or atorvastatin on platelet aggregation in patients treated with clopidogrel.
应用推荐